Literature DB >> 7579537

Insulin inhibits its own secretion from isolated, perifused human pancreatic islets.

P Marchetti1, D W Scharp, M McLear, E H Finke, B Olack, C Swanson, R Giannarelli, R Navalesi, P E Lacy.   

Abstract

It is still a controversial question whether insulin suppresses its own secretion. We prepared pure human islets from three pancreases by collagenase digestion and density gradient purification. Aliquots of 200 islet equivalents (IE, 150-microns sized-islets) were sequentially perifused at 37 degrees C with 3.3 mmol/l glucose (3.3G, 40 min), 16.7 mmol/l glucose (16.7G, 30 min) and again 3.3G (30 min) after 24 h, 37 degrees C culture in CMRL 1066 medium with or without the addition of either 200 or 400 microU/ml human insulin in the incubation medium (6 replicates each). Insulin secretion was assessed by C-peptide (Cp) measurement in the perifusate. Without added insulin (C) and with 200 (Ins200) or 400 (Ins400) microU/ml added insulin, basal Cp release was 0.12 +/- 0.03, 0.14 +/- 0.02 and 0.14 +/- 0.04 ng/ml, respectively. At 16.7G, the first-phase secretion peak (expressed as Cp value) was significantly lower with Ins200 (0.47 +/- 0.13 ng/ml, P < 0.02) and Ins400 (0.68 +/- 0.15 ng/ml, P < 0.05) than C (0.83 +/- 0.15 ng/ml). The second-phase secretion peak was also significantly (P < 0.05) reduced with added insulin (Ins200: 0.47 +/- 0.08 ng/ml; Ins400: 0.45 +/- 0.07 ng/ml) than in its absence (C: 0.65 +/- 0.09 ng/ml). Accordingly, total Cp secretion was lower with Ins200 (10.6 +/- 2.3 ng/ml, P = 0.03) and Ins400 (11.8 +/- 2.3 ng/ml) than with C (16.0 +/- 2.2 ng/ml).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7579537     DOI: 10.1007/BF00569560

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  17 in total

1.  Evaluation of the role of exogenous insulin on phasic insulin secretion.

Authors:  G M Grodsky; R Fanska; F G Schmid
Journal:  Diabetes       Date:  1973-04       Impact factor: 9.461

2.  Evidence for an insulin-induced inhibition of insulin release by isolated islets of Langerhans.

Authors:  J C Sodoyez; F Sodoyez-Goffaux; P P Foà
Journal:  Proc Soc Exp Biol Med       Date:  1969-02

3.  Quantitative electron microscopic autoradiography of insulin, glucagon, and somatostatin binding sites on islets.

Authors:  Y C Patel; M Amherdt; L Orci
Journal:  Science       Date:  1982-09-17       Impact factor: 47.728

4.  Automated method for isolation of human pancreatic islets.

Authors:  C Ricordi; P E Lacy; E H Finke; B J Olack; D W Scharp
Journal:  Diabetes       Date:  1988-04       Impact factor: 9.461

5.  The independence of insulin release and ambient insulin in vitro.

Authors:  F Marincola; W Frank; W Clark; M Douglas; R Merrell
Journal:  Diabetes       Date:  1983-12       Impact factor: 9.461

6.  Failure of exogenous insulin to inhibit C-peptide release from the perfused rat pancreas.

Authors:  R Tanaka; K Shima; N Sawazaki; T Matsuyama; Y Kumahara; N Yanaihara
Journal:  Endocrinol Jpn       Date:  1980-06

7.  Low-temperature culture of human islets isolated by the distention method and purified with Ficoll or Percoll gradients.

Authors:  D W Scharp; P E Lacy; E Finke; B Olack
Journal:  Surgery       Date:  1987-11       Impact factor: 3.982

8.  Evidence for presence of insulin receptors in rat islets of Langerhans.

Authors:  E J Verspohl; H P Ammon
Journal:  J Clin Invest       Date:  1980-05       Impact factor: 14.808

9.  Feedback inhibition of insulin on insulin secretion in isolated pancreatic islets.

Authors:  B Draznin; M Goodman; J W Leitner; K E Sussman
Journal:  Endocrinology       Date:  1986-03       Impact factor: 4.736

10.  Evidence for the presence of type I insulin-like growth factor receptors on rat pancreatic A and B cells.

Authors:  C F Van Schravendijk; A Foriers; J L Van den Brande; D G Pipeleers
Journal:  Endocrinology       Date:  1987-11       Impact factor: 4.736

View more
  4 in total

1.  Attenuation of insulin secretion by insulin-like growth factor 1 is mediated through activation of phosphodiesterase 3B.

Authors:  A Z Zhao; H Zhao; J Teague; W Fujimoto; J A Beavo
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

Review 2.  Targeting pancreatic β cells for diabetes treatment.

Authors:  Chirag Jain; Sara Bilekova; Heiko Lickert
Journal:  Nat Metab       Date:  2022-09-21

Review 3.  Cyclic nucleotide phosphodiesterases in pancreatic islets.

Authors:  N J Pyne; B L Furman
Journal:  Diabetologia       Date:  2003-08-07       Impact factor: 10.122

4.  Improved in vivo imaging method for individual islets across the mouse pancreas reveals a heterogeneous insulin secretion response to glucose.

Authors:  Henriette Frikke-Schmidt; Peter Arvan; Randy J Seeley; Corentin Cras-Méneur
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.